Cidara Therapeutics, Inc. Announces Resignation of James Levine as the Chief Financial Officer, Effective as of July 9, 2021
July 01, 2021 at 09:12 pm
Effective as of July 9, 2021, James Levine resigned from his position as the Chief Financial Officer, including as the principal financial officer and principal accounting officer, of Cidara Therapeutics, Inc. (the “Company”). Mr. Levine has agreed to serve as a consultant to the Company for at least the six month period following his resignation to assist with a smooth transition of his duties, and his Company equity awards will continue to vest during such period of transition services.